For the Inventor, By the Inventor

Enter assignee name

Chestnut Ridge, NY, United States of America

Par Pharmaceutical, Inc.

USPTO Granted Patents = 43

CIPO Patents = 2

Trademarks = 31

Forward Citations = 229

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Vinayagam Kannan (23 out of 23 patents)

Matthew Kenney (20 out of 22 patents)

Suketu Sanghvi (19 out of 29 patents)

4. Sunil Vandse (17 out of 20 patents)

5. Anthony P Sileno (7 out of 18 patents)

6. Zenaida Go (7 out of 11 patents)

7. Steven C Quay (7 out of 93 patents)

8. Satish Shamlal Patil (5 out of 5 patents)

9. Peter C Aprile (4 out of 6 patents)

10. Robert Ruemer (4 out of 4 patents)

11. Narayan Ragunathan (4 out of 7 patents)

12. Robert A Femia (4 out of 8 patents)

13. Mohankumar Lakshmanan (4 out of 4 patents)

14. Selvakumar Viruthagiri (4 out of 4 patents)

15. Somasundaram Muthuramalingam (4 out of 4 patents)

Core Competencies:

Vasopressin Formulations

Epinephrine Formulations

Varenicline Compound

Sugammadex Pre-filled Syringe

Cyanocobalamin Formulations

Intranasal Delivery

Nasal Calcitonin Formulations

Chlorobutanol

Hypotension Treatment

Cyanomethyl Ester Precursors

Data Sorting Methods

43 patents: Sort by Forward Citations

1. 12186362 - Vasopressin formulations for use in treatment of hypotension (2025-01-07),

2. 11872234 - Vareniciline compound and process of manufacture thereof (2024-01-16),

3. 11779587 - Vareniciline compound and process of manufacture thereof (2023-10-10),

4. 11717524 - Varenicline compound and process of manufacture thereof (2023-08-08),

5. 11602537 - Varenicline compound and process of manufacture thereof (2023-03-14),

6. 11337938 - Epinephrine formulations (2022-05-24),

7. 11207372 - Vasopressin formulations for use in treatment of hypotension (2021-12-28),

8. 11135265 - Vasopressin formulations for use in treatment of hypotension (2021-10-05),

9. 11097023 - Pre-filled syringe containing sugammadex (2021-08-24),

10. 10920278 - Method to treat hypotension using vasopressin in certain genotypes (2021-02-16),

11. 10844435 - Method to treat hypotension using vasopressin in certain genotypes (2020-11-24),

12. 10624864 - Epinephrine formulations (2020-04-21),

13. 10130592 - Epinephrine formulations (2018-11-20),

14. 10010575 - Vasopressin formulations for use in treatment of hypotension (2018-07-03),

15. 9993520 - Vasopressin formulations for use in treatment of hypotension (2018-06-12),

PAR Pharmaceutical, Inc. is a leading global specialty pharmaceutical company that develops, manufactures, and markets high-quality and affordable generic drugs. With a diverse product portfolio, PAR focuses on providing innovative solutions to improve patient access to essential medications. The company is dedicated to upholding the highest standards of quality, safety, and reliability in all its operations.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

43 Patents

#2 in Chestnut Ridge, NY

#448 in New York

#7,823 in US

#15,579 in the World

Chestnut Ridge, NY, United States of America

Par Pharmaceutical, Inc.

Forward Citations = 229

32 inventors:

Vinayagam Kannan (23 out of 23 patents)

Matthew Kenney (20 out of 22 patents)

Suketu Sanghvi (19 out of 29 patents)

4. Sunil Vandse (17 out of 20 patents)

5. Anthony P Sileno (7 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…